| Year |
Citation |
Score |
| 2018 |
Mabrey FL, Chien SS, Martins TS, Annis J, Sekizaki TS, Dai J, Beckman RA, Loeb LA, Carson A, Patay B, Blau CA, Oehler VG, Celik SS, Lee S, Monnat RJ, et al. High Throughput Drug Screening of Leukemia Stem Cells Reveals Resistance to Standard Therapies and Sensitivity to Other Agents in Acute Myeloid Leukemia Blood. 132: 180-180. DOI: 10.1182/Blood-2018-180 |
0.32 |
|
| 2015 |
Sperber H, Mathieu J, Wang Y, Ferreccio A, Hesson J, Xu Z, Fischer KA, Devi A, Detraux D, Gu H, Battle SL, Showalter M, Valensisi C, Bielas JH, Ericson NG, ... ... Blau CA, et al. The metabolome regulates the epigenetic landscape during naive-to-primed human embryonic stem cell transition. Nature Cell Biology. PMID 26571212 DOI: 10.1038/Ncb3264 |
0.659 |
|
| 2015 |
Ma W, Ay F, Lee C, Gulsoy G, Deng X, Cook S, Hesson J, Cavanaugh C, Ware CB, Krumm A, Shendure J, Blau CA, Disteche CM, Noble WS, Duan Z. Fine-scale chromatin interaction maps reveal the cis-regulatory landscape of human lincRNA genes. Nature Methods. 12: 71-8. PMID 25437436 DOI: 10.1038/Nmeth.3205 |
0.319 |
|
| 2015 |
Belay E, Miller CP, Kortum AN, Torok-Storb B, Blau CA, Emery DW. A hyperactive Mpl-based cell growth switch drives macrophage-associated erythropoiesis through an erythroid-megakaryocytic precursor. Blood. 125: 1025-33. PMID 25343958 DOI: 10.1182/blood-2014-02-555318 |
0.389 |
|
| 2014 |
Ware CB, Nelson AM, Mecham B, Hesson J, Zhou W, Jonlin EC, Jimenez-Caliani AJ, Deng X, Cavanaugh C, Cook S, Tesar PJ, Okada J, Margaretha L, Sperber H, Choi M, ... Blau CA, et al. Derivation of naive human embryonic stem cells. Proceedings of the National Academy of Sciences of the United States of America. 111: 4484-9. PMID 24623855 DOI: 10.1073/Pnas.1319738111 |
0.654 |
|
| 2012 |
Zhou W, Choi M, Margineantu D, Margaretha L, Hesson J, Cavanaugh C, Blau CA, Horwitz MS, Hockenbery D, Ware C, Ruohola-Baker H. HIF1α induced switch from bivalent to exclusively glycolytic metabolism during ESC-to-EpiSC/hESC transition. The Embo Journal. 31: 2103-16. PMID 22446391 DOI: 10.1038/Emboj.2012.71 |
0.645 |
|
| 2011 |
Mathieu J, Zhang Z, Zhou W, Wang AJ, Heddleston JM, Pinna CM, Hubaud A, Stadler B, Choi M, Bar M, Tewari M, Liu A, Vessella R, Rostomily R, Born D, ... ... Blau CA, et al. HIF induces human embryonic stem cell markers in cancer cells. Cancer Research. 71: 4640-52. PMID 21712410 DOI: 10.1158/0008-5472.Can-10-3320 |
0.404 |
|
| 2010 |
Stadler B, Ivanovska I, Mehta K, Song S, Nelson A, Tan Y, Mathieu J, Darby C, Blau CA, Ware C, Peters G, Miller DG, Shen L, Cleary MA, Ruohola-Baker H. Characterization of microRNAs involved in embryonic stem cell states. Stem Cells and Development. 19: 935-50. PMID 20128659 DOI: 10.1089/Scd.2009.0426 |
0.339 |
|
| 2009 |
Ware CB, Wang L, Mecham BH, Shen L, Nelson AM, Bar M, Lamba DA, Dauphin DS, Buckingham B, Askari B, Lim R, Tewari M, Gartler SM, Issa JP, Pavlidis P, ... ... Blau CA, et al. Histone deacetylase inhibition elicits an evolutionarily conserved self-renewal program in embryonic stem cells. Cell Stem Cell. 4: 359-69. PMID 19341625 DOI: 10.1016/J.Stem.2009.03.001 |
0.512 |
|
| 2008 |
Lin EH, Jiang Y, Deng Y, Lapsiwala R, Lin T, Blau CA. Cancer stem cells, endothelial progenitors, and mesenchymal stem cells: "seed and soil" theory revisited. Gastrointestinal Cancer Research : Gcr. 2: 169-74. PMID 19259284 |
0.393 |
|
| 2006 |
Blau CA, Peterson KR. Establishment of cell lines that exhibit correct ontogenic stage-specific gene expression profiles from tissues of yeast artificial chromosome transgenic mice using chemically induced growth signals Methods in Molecular Biology (Clifton, N.J.). 349: 163-173. PMID 17071982 |
0.349 |
|
| 2006 |
Nagasawa Y, Wood BL, Wang L, Lintmaer I, Guo W, Papayannopoulou T, Harkey MA, Nourigat C, Blau CA. Anatomical compartments modify the response of human hematopoietic cells to a mitogenic signal Stem Cells. 24: 908-917. PMID 16373691 DOI: 10.1634/stemcells.2005-0484 |
0.436 |
|
| 2005 |
Blau CA, Barbas CF, Bomhoff AL, Neades R, Yan J, Navas PA, Peterson KR. γ-globin gene expression in chemical inducer of dimerization (CID)-dependent multipotential cells established from human β-globin locus yeast artificial chromosome (β-YAC) transgenic mice Journal of Biological Chemistry. 280: 36642-36647. PMID 16131492 DOI: 10.1074/jbc.M504402200 |
0.318 |
|
| 2005 |
Richard RE, Siritanaratkul N, Jonlin E, Skarpidi E, Heimfeld S, Blau CA. Collection of blood stem cells from patients with sickle cell anemia. Blood Cells, Molecules & Diseases. 35: 384-8. PMID 16125985 DOI: 10.1016/j.bcmd.2005.06.014 |
0.41 |
|
| 2005 |
Emery DW, Tubb J, Nishino Y, Nishino T, Otto KG, Stamatoyannopoulos G, Blau CA. Selection with a regulated cell growth switch increases the likelihood of expression for a linked gamma-globin gene. Blood Cells, Molecules & Diseases. 34: 235-47. PMID 15885608 DOI: 10.1016/j.bcmd.2005.01.004 |
0.402 |
|
| 2004 |
Richard RE, De Claro RA, Yan J, Chien S, Von Recum H, Morris J, Kiem HP, Dalgarno DC, Heimfeld S, Clackson T, Andrews R, Blau CA. Differences in F36VMpl-based in vivo selection among large animal models. Molecular Therapy : the Journal of the American Society of Gene Therapy. 10: 730-40. PMID 15451457 DOI: 10.1016/j.ymthe.2004.07.005 |
0.318 |
|
| 2004 |
Zhao S, Weinreich MA, Ihara K, Richard RE, Blau CA. In vivo selection of genetically modified erythroid cells using a jak2-based cell growth switch. Molecular Therapy : the Journal of the American Society of Gene Therapy. 10: 456-68. PMID 15336646 DOI: 10.1016/J.Ymthe.2004.05.014 |
0.302 |
|
| 2004 |
Zhao SM, Gu XC, Chang NB, Clackson T, Blau CA. [Long term regulated expansion and committed differentiation of JAK2 gene transfected hematopoietic stem/progenitor cells in vitro]. Zhonghua Xue Ye Xue Za Zhi = Zhonghua Xueyexue Zazhi. 25: 65-9. PMID 14990041 |
0.458 |
|
| 2004 |
Berger C, Blau CA, Huang ML, Iuliucci JD, Dalgarno DC, Gaschet J, Heimfeld S, Clackson T, Riddell SR. Pharmacologically regulated Fas-mediated death of adoptively transferred T cells in a nonhuman primate model. Blood. 103: 1261-9. PMID 14563634 DOI: 10.1182/blood-2003-08-2908 |
0.326 |
|
| 2003 |
Richard RE, Blau CA. Small-molecule-directed mpl signaling can complement growth factors to selectively expand genetically modified cord blood cells. Stem Cells (Dayton, Ohio). 21: 71-8. PMID 12529553 DOI: 10.1634/stemcells.21-1-71 |
0.408 |
|
| 2000 |
Richard RE, Wood B, Zeng H, Jin L, Papayannopoulou T, Blau CA. Expansion of genetically modified primary human hemopoietic cells using chemical inducers of dimerization. Blood. 95: 430-6. PMID 10627446 |
0.42 |
|
| 1998 |
Blau CA. Current status of stem cell therapy and prospects for gene therapy for the disorders of globin synthesis. BaillièRe's Clinical Haematology. 11: 257-75. PMID 10872481 |
0.378 |
|
| 1997 |
Blau CA, Neff T, Papayannopoulou T. Cytokine prestimulation as a gene therapy strategy: implications for using the MDR1 gene as a dominant selectable marker. Blood. 89: 146-54. PMID 8978287 |
0.382 |
|
| 1996 |
Blau CA, Neff T, Papayannopoulou T. The hematological effects of folate analogs: implications for using the dihydrofolate reductase gene for in vivo selection. Human Gene Therapy. 7: 2069-78. PMID 8934221 DOI: 10.1089/hum.1996.7.17-2069 |
0.392 |
|
| 1994 |
Stamatoyannopoulos G, Blau CA, Nakamoto B, Josephson B, Li Q, Liakopoulou E, Pace B, Papayannopoulou T, Brusilow SW, Dover G. Fetal hemoglobin induction by acetate, a product of butyrate catabolism. Blood. 84: 3198-204. PMID 7524768 DOI: 10.1182/Blood.V84.9.3198.3198 |
0.322 |
|
| 1993 |
Papayannopoulou T, Brice M, Blau CA. Kit ligand in synergy with interleukin-3 amplifies the erythropoietin-independent, globin-synthesizing progeny of normal human burst-forming units-erythroid in suspension cultures: physiologic implications. Blood. 81: 299-310. PMID 7678508 DOI: 10.1182/Blood.V81.2.299.Bloodjournal812299 |
0.52 |
|
| 1991 |
Abkowitz JL, Sabo KM, Nakamoto B, Blau CA, Martin FH, Zsebo KM, Papayannopoulou T. Diamond-blackfan anemia: in vitro response of erythroid progenitors to the ligand for c-kit. Blood. 78: 2198-202. PMID 1718487 DOI: 10.1182/Blood.V78.9.2198.2198 |
0.378 |
|
| Low-probability matches (unlikely to be authored by this person) |
| 2015 |
Deng X, Ma W, Ramani V, Hill A, Yang F, Ay F, Berletch JB, Blau CA, Shendure J, Duan Z, Noble WS, Disteche CM. Bipartite structure of the inactive mouse X chromosome. Genome Biology. 16: 152. PMID 26248554 DOI: 10.1186/S13059-015-0728-8 |
0.296 |
|
| 2000 |
Jin L, Zeng H, Chien S, Otto KG, Richard RE, Emery DW, Blau CA. In vivo selection using a cell-growth switch. Nature Genetics. 26: 64-6. PMID 10973250 DOI: 10.1038/79194 |
0.291 |
|
| 2003 |
Berger C, Blau CA, Clackson T, Riddell SR, Heimfeld S. CD28 costimulation and immunoaffinity-based selection efficiently generate primary gene-modified T cells for adoptive immunotherapy. Blood. 101: 476-84. PMID 12393495 DOI: 10.1182/blood-2002-07-2142 |
0.29 |
|
| 1998 |
Abboud M, Laver J, Blau CA. Granulocytosis causing sickle-cell crisis. Lancet (London, England). 351: 959. PMID 9734950 DOI: 10.1016/S0140-6736(05)60614-9 |
0.287 |
|
| 2010 |
Becker PS, Miller CP, Wood BL, Chien S, Bensinger W, Shahijanian F, Blau CA. Expression of erythropoietin receptors by plasma cells from patients with multiple myeloma: Potential relevance to pharmacological use of erythropoietin. Journal of Clinical Oncology. 28: 8124-8124. DOI: 10.1200/Jco.2010.28.15_Suppl.8124 |
0.287 |
|
| 2019 |
Becker PS, Oehler VG, Blau CA, Martins TS, Curley N, Chien S, Dai J, Kauer N, Yeung KY, Hung L, Hammer C, Hendrie PC, Percival MM, Cassaday RD, Scott BL, et al. A Multi-Omic Precision Medicine Clinical Trial in Acute Leukemia Blood. 134: 1269-1269. DOI: 10.1182/Blood-2019-130996 |
0.284 |
|
| 2002 |
Neff T, Horn PA, Valli VE, Gown AM, Wardwell S, Wood BL, von Kalle C, Schmidt M, Peterson LJ, Morris JC, Richard RE, Clackson T, Kiem HP, Blau CA. Pharmacologically regulated in vivo selection in a large animal. Blood. 100: 2026-31. PMID 12200362 DOI: 10.1182/Blood-2002-03-0792 |
0.284 |
|
| 2004 |
Kiem HP, Sellers S, Thomasson B, Morris JC, Tisdale JF, Horn PA, Hematti P, Adler R, Kuramoto K, Calmels B, Bonifacino A, Hu J, von Kalle C, Schmidt M, Sorrentino B, ... ... Blau CA, et al. Long-term clinical and molecular follow-up of large animals receiving retrovirally transduced stem and progenitor cells: no progression to clonal hematopoiesis or leukemia. Molecular Therapy : the Journal of the American Society of Gene Therapy. 9: 389-95. PMID 15006605 DOI: 10.1016/J.Ymthe.2003.12.006 |
0.28 |
|
| 2001 |
Otto KG, Broudy VC, Lin NL, Parganas E, Luthi JN, Drachman JG, Ihle JN, Blau CA. Membrane localization is not required for Mpl function in normal hematopoietic cells. Blood. 98: 2077-83. PMID 11567993 DOI: 10.1182/Blood.V98.7.2077 |
0.279 |
|
| 2001 |
Zeng H, Masuko M, Jin L, Neff T, Otto KG, Blau CA. Receptor specificity in the self-renewal and differentiation of primary multipotential hemopoietic cells. Blood. 98: 328-34. PMID 11435300 |
0.278 |
|
| 2006 |
Weinreich MA, Lintmaer I, Wang L, Liggitt HD, Harkey MA, Blau CA. Growth factor receptors as regulators of hematopoiesis. Blood. 108: 3713-21. PMID 16902155 DOI: 10.1182/Blood-2006-01-012278 |
0.276 |
|
| 1995 |
Liakopoulou E, Blau CA, Li Q, Josephson B, Wolf JA, Fournarakis B, Raisys V, Dover G, Papayannopoulou T, Stamatoyannopoulos G. Stimulation of fetal hemoglobin production by short chain fatty acids. Blood. 86: 3227-35. PMID 7579419 DOI: 10.1182/Blood.V86.8.3227.3227 |
0.266 |
|
| 2007 |
Wang L, Schulz TC, Sherrer ES, Dauphin DS, Shin S, Nelson AM, Ware CB, Zhan M, Song CZ, Chen X, Brimble SN, McLean A, Galeano MJ, Uhl EW, D'Amour KA, ... ... Blau CA, et al. Self-renewal of human embryonic stem cells requires insulin-like growth factor-1 receptor and ERBB2 receptor signaling. Blood. 110: 4111-9. PMID 17761519 DOI: 10.1182/Blood-2007-03-082586 |
0.263 |
|
| 2008 |
Blau CA, Miller CP, Lowe KA, Mattern D, Valliant-Saunders K, Urban N, Henke M. Predictive testing for erythropoietin induced tumor progression in head and neck cancer Journal of Clinical Oncology. 26: 11007-11007. DOI: 10.1200/Jco.2008.26.15_Suppl.11007 |
0.257 |
|
| 2010 |
Miller CP, Valliant-Saunders K, Blau CA. Limitations of a murine transgenic breast cancer model for studies of erythropoietin-induced tumor progression. Translational Oncology. 3: 176-80. PMID 20563259 DOI: 10.1593/Tlo.09304 |
0.256 |
|
| 2012 |
Kacherovsky N, Harkey MA, Blau CA, Giachelli CM, Pun SH. Combination of Sleeping Beauty transposition and chemically induced dimerization selection for robust production of engineered cells. Nucleic Acids Research. 40: e85. PMID 22402491 DOI: 10.1093/Nar/Gks213 |
0.252 |
|
| 2006 |
Ware CB, Nelson AM, Blau CA. A comparison of NIH-approved human ESC lines. Stem Cells (Dayton, Ohio). 24: 2677-84. PMID 16916927 DOI: 10.1634/Stemcells.2005-0452 |
0.251 |
|
| 1993 |
Blau CA, Constantoulakis P, al-Khatti A, Spadaccino E, Goldwasser E, Papayannopoulou T, Stamatoyannopoulos G. Fetal hemoglobin in acute and chronic states of erythroid expansion. Blood. 81: 227-33. PMID 7678067 DOI: 10.1182/Blood.V81.1.227.227 |
0.25 |
|
| 1993 |
Blau CA, Constantoulakis P, Shaw CM, Stamatoyannopoulos G. Fetal hemoglobin induction with butyric acid: efficacy and toxicity. Blood. 81: 529-37. PMID 8422469 DOI: 10.1182/Blood.V81.2.529.529 |
0.247 |
|
| 2007 |
Harkey MA, Kaul R, Jacobs MA, Kurre P, Bovee D, Levy R, Blau CA. Multiarm high-throughput integration site detection: limitations of LAM-PCR technology and optimization for clonal analysis. Stem Cells and Development. 16: 381-92. PMID 17610368 DOI: 10.1089/Scd.2007.0015 |
0.246 |
|
| 1998 |
Jin L, Siritanaratkul N, Emery DW, Richard RE, Kaushansky K, Papayannopoulou T, Blau CA. Targeted expansion of genetically modified bone marrow cells. Proceedings of the National Academy of Sciences of the United States of America. 95: 8093-7. PMID 9653145 DOI: 10.1073/Pnas.95.14.8093 |
0.244 |
|
| 1999 |
Jin L, Neff T, Blau CA. Marrow sensitization to 5-fluorouracil using the ligands for Flt-3 and c-Kit. Experimental Hematology. 27: 520-5. PMID 10089915 |
0.243 |
|
| 2003 |
Kohn DB, Sadelain M, Dunbar C, Bodine D, Kiem HP, Candotti F, Tisdale J, Riviére I, Blau CA, Richard RE, Sorrentino B, Nolta J, Malech H, Brenner M, Cornetta K, et al. American Society of Gene Therapy (ASGT) ad hoc subcommittee on retroviral-mediated gene transfer to hematopoietic stem cells. Molecular Therapy : the Journal of the American Society of Gene Therapy. 8: 180-7. PMID 12907140 DOI: 10.1016/S1525-0016(03)00212-0 |
0.242 |
|
| 2004 |
Richard RE, Weinreich M, Chang KH, Ieremia J, Stevenson MM, Blau CA. Modulating erythrocyte chimerism in a mouse model of pyruvate kinase deficiency. Blood. 103: 4432-9. PMID 14988153 DOI: 10.1182/Blood-2003-10-3705 |
0.236 |
|
| 2001 |
Neff T, Blau CA. Pharmacologically regulated cell therapy. Blood. 97: 2535-40. PMID 11313238 |
0.235 |
|
| 2009 |
Miller CP, Loeb K, Edlefsen K, Urban N, Blau CA. Localization of erythropoietin receptor mRNA in primary breast tumors by laser capture microdissection. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 27: e22036. PMID 27963153 DOI: 10.1200/Jco.2009.27.15_Suppl.E22036 |
0.232 |
|
| 2015 |
Campton DE, Ramirez AB, Nordberg JJ, Drovetto N, Clein AC, Varshavskaya P, Friemel BH, Quarre S, Breman A, Dorschner M, Blau S, Blau CA, Sabath DE, Stilwell JL, Kaldjian EP. High-recovery visual identification and single-cell retrieval of circulating tumor cells for genomic analysis using a dual-technology platform integrated with automated immunofluorescence staining. Bmc Cancer. 15: 360. PMID 25944336 DOI: 10.1186/S12885-015-1383-X |
0.228 |
|
| 2002 |
Zhao S, Zoller K, Masuko M, Rojnuckarin P, Yang XO, Parganas E, Kaushansky K, Ihle JN, Papayannopoulou T, Willerford DM, Clackson T, Blau CA. JAK2, complemented by a second signal from c-kit or flt-3, triggers extensive self-renewal of primary multipotential hemopoietic cells. The Embo Journal. 21: 2159-67. PMID 11980713 DOI: 10.1093/Emboj/21.9.2159 |
0.226 |
|
| 1998 |
Li Q, Blau CA, Clegg CH, Rohde A, Stamatoyannopoulos G. Multiple epsilon-promoter elements participate in the developmental control of epsilon-globin genes in transgenic mice. The Journal of Biological Chemistry. 273: 17361-7. PMID 9651319 |
0.223 |
|
| 2012 |
Duan Z, Blau CA. The genome in space and time: does form always follow function? How does the spatial and temporal organization of a eukaryotic genome reflect and influence its functions? Bioessays : News and Reviews in Molecular, Cellular and Developmental Biology. 34: 800-10. PMID 22777837 DOI: 10.1002/Bies.201200034 |
0.223 |
|
| 2013 |
Blau CA, Miller CP, Kortum AN, Thorpe JD, Schummer M, O'Briant K, Coy CM, Beatty JD, Urban ND. Evaluating the prognostic significance of JAK2 in distant breast cancer recurrence. Journal of Clinical Oncology. 31. DOI: 10.1200/Jco.2013.31.15_Suppl.E22178 |
0.221 |
|
| 2015 |
Becker PS, Schmitt MW, Loeb LA, Gu W, Wei Q, Xie Z, Carson AR, Martins T, Blau CA, Oehler V, Yeung KY. Correlation of genomic analysis by MyAML with chemotherapy drug sensitivity. Journal of Clinical Oncology. 33: 7080-7080. DOI: 10.1200/Jco.2015.33.15_Suppl.7080 |
0.216 |
|
| 1997 |
Blau CA, Peterson KR, Drachman JG, Spencer DM. A proliferation switch for genetically modified cells Proceedings of the National Academy of Sciences of the United States of America. 94: 3076-3081. PMID 9096348 DOI: 10.1073/pnas.94.7.3076 |
0.206 |
|
| 2005 |
Ware CB, Nelson AM, Blau CA. Controlled-rate freezing of human ES cells. Biotechniques. 38: 879-80, 882-3. PMID 16018548 DOI: 10.2144/05386St01 |
0.2 |
|
| 2001 |
Whitney ML, Otto KG, Blau CA, Reinecke H, Murry CE. Control of myoblast proliferation with a synthetic ligand. The Journal of Biological Chemistry. 276: 41191-6. PMID 11502737 DOI: 10.1074/Jbc.M103191200 |
0.197 |
|
| 1998 |
Jin L, Asano H, Blau CA. Stimulating cell proliferation through the pharmacologic activation of c-kit. Blood. 91: 890-7. PMID 9446649 |
0.189 |
|
| 1996 |
Neff T, Blau CA. Forced expression of cytidine deaminase confers resistance to cytosine arabinoside and gemcitabine. Experimental Hematology. 24: 1340-6. PMID 8862446 |
0.184 |
|
| 2005 |
Gandhi MJ, Pendergrass TW, Cummings CC, Ihara K, Blau CA, Drachman JG. Congenital amegakaryocytic thrombocytopenia in three siblings: molecular analysis of atypical clinical presentation. Experimental Hematology. 33: 1215-21. PMID 16219544 DOI: 10.1016/j.exphem.2005.06.017 |
0.179 |
|
| 2008 |
Miller CP, Blau CA. Using gene transfer to circumvent off-target effects. Gene Therapy. 15: 759-64. PMID 18356813 DOI: 10.1038/gt.2008.43 |
0.175 |
|
| 1994 |
Blau CA, Stamatoyannopoulos G. Hemoglobin switching and its clinical implications. Current Opinion in Hematology. 1: 136-42. PMID 9371272 |
0.172 |
|
| 2015 |
Logsdon BA, Gentles AJ, Miller CP, Blau CA, Becker PS, Lee SI. Sparse expression bases in cancer reveal tumor drivers. Nucleic Acids Research. 43: 1332-44. PMID 25583238 DOI: 10.1093/Nar/Gku1290 |
0.171 |
|
| 2014 |
Miller CP, Thorpe JD, Kortum AN, Coy CM, Cheng WY, Ou Yang TH, Anastassiou D, Beatty JD, Urban ND, Blau CA. JAK2 expression is associated with tumor-infiltrating lymphocytes and improved breast cancer outcomes: implications for evaluating JAK2 inhibitors. Cancer Immunology Research. 2: 301-6. PMID 24764577 DOI: 10.1158/2326-6066.Cir-13-0189 |
0.163 |
|
| 2002 |
Li ZY, Otto K, Richard RE, Ni S, Kirillova I, Fausto N, Blau CA, Lieber A. Dimerizer-induced proliferation of genetically modified hepatocytes. Molecular Therapy : the Journal of the American Society of Gene Therapy. 5: 420-6. PMID 11945069 DOI: 10.1006/Mthe.2002.0565 |
0.159 |
|
| 2002 |
Ieremia J, Blau CA. Limitations of a mouse model of sickle cell anemia. Blood Cells, Molecules & Diseases. 28: 146-51. PMID 12064910 |
0.156 |
|
| 2011 |
Okazuka K, Beard BC, Emery DW, Schwarzwaelder K, Spector MR, Sale GE, von Kalle C, Torok-Storb B, Kiem HP, Blau CA. Long-term regulation of genetically modified primary hematopoietic cells in dogs. Molecular Therapy : the Journal of the American Society of Gene Therapy. 19: 1287-94. PMID 21326218 DOI: 10.1038/Mt.2011.8 |
0.156 |
|
| 2001 |
Otto KG, Jin L, Spencer DM, Blau CA. Cell proliferation through forced engagement of c-Kit and Flt-3. Blood. 97: 3662-4. PMID 11369667 DOI: 10.1182/blood.V97.11.3662 |
0.15 |
|
| 2016 |
Blau CA, Ramirez AB, Blau S, Pritchard CC, Dorschner MO, Schmechel SC, Martins TJ, Mahen EM, Burton KA, Komashko VM, Radenbaugh AJ, Dougherty K, Thomas A, Miller CP, Annis J, et al. A Distributed Network for Intensive Longitudinal Monitoring in Metastatic Triple-Negative Breast Cancer. Journal of the National Comprehensive Cancer Network : Jnccn. 14: 8-17. PMID 26733551 DOI: 10.6004/Jnccn.2016.0003 |
0.14 |
|
| 1999 |
Blau CA. In vivo selection of genetically modified bone marrow cells. Progress in Experimental Tumor Research. 36: 162-71. PMID 10386072 |
0.139 |
|
| 1993 |
Blau CA. Induction of fetal hemoglobin with erythropoietin. Nephron. 65: 336. PMID 7504214 |
0.137 |
|
| 2015 |
Lawrence RT, Perez EM, Hernández D, Miller CP, Haas KM, Irie HY, Lee SI, Blau CA, Villén J. The proteomic landscape of triple-negative breast cancer. Cell Reports. 11: 630-44. PMID 25892236 DOI: 10.1016/J.Celrep.2015.03.050 |
0.115 |
|
| 2009 |
Miller CP, Lowe KA, Valliant-Saunders K, Kaiser JF, Mattern D, Urban N, Henke M, Blau CA. Evaluating erythropoietin-associated tumor progression using archival tissues from a phase III clinical trial Stem Cells. 27: 2353-2361. PMID 19544471 DOI: 10.1002/stem.156 |
0.113 |
|
| 2014 |
Zare H, Wang J, Hu A, Weber K, Smith J, Nickerson D, Song C, Witten D, Blau CA, Noble WS. Inferring clonal composition from multiple sections of a breast cancer. Plos Computational Biology. 10: e1003703. PMID 25010360 DOI: 10.1200/Jco.2014.32.15_Suppl.11077 |
0.106 |
|
| 2012 |
Noble WS, Blau CA, Dekker J, Duan ZJ, Mao Y. The structure and function of chromatin and chromosomes. Pacific Symposium On Biocomputing. Pacific Symposium On Biocomputing. 434-40. PMID 22174298 |
0.08 |
|
| 2010 |
Duan Z, Andronescu M, Schutz K, McIlwain S, Kim YJ, Lee C, Shendure J, Fields S, Blau CA, Noble WS. A three-dimensional model of the yeast genome. Nature. 465: 363-7. PMID 20436457 DOI: 10.1038/Nature08973 |
0.078 |
|
| 2011 |
Miller CP, Urban N, Blau CA. Quantitative comparison of erythropoietin receptor levels in the epithelial versus endothelial fractions of primary breast tumors Anticancer Research. 31: 1189-1195. PMID 21508364 |
0.078 |
|
| 2013 |
Blau CA, Liakopoulou E. Can we deconstruct cancer, one patient at a time? Trends in Genetics : Tig. 29: 6-10. PMID 23102584 DOI: 10.1016/j.tig.2012.09.004 |
0.061 |
|
| 2007 |
Blau CA. Erythropoietin in cancer: presumption of innocence? Stem Cells (Dayton, Ohio). 25: 2094-7. PMID 17464082 DOI: 10.1634/stemcells.2007-0229 |
0.058 |
|
| 2008 |
Bennett CL, Silver SM, Djulbegovic B, Samaras AT, Blau CA, Gleason KJ, Barnato SE, Elverman KM, Courtney DM, McKoy JM, Edwards BJ, Tigue CC, Raisch DW, Yarnold PR, Dorr DA, et al. Venous thromboembolism and mortality associated with recombinant erythropoietin and darbepoetin administration for the treatment of cancer-associated anemia. Jama. 299: 914-24. PMID 18314434 DOI: 10.1001/jama.299.8.914 |
0.053 |
|
| 2012 |
Blau CA. Can intensive longitudinal monitoring of individuals advance cancer research? The Oncologist. 17: 587-9. PMID 22523197 DOI: 10.1634/theoncologist.2012-0122 |
0.041 |
|
| 1993 |
Blau CA. Therapy for globin-chain disorders. The New England Journal of Medicine. 329: 364. PMID 8321277 DOI: 10.1056/NEJM199307293290519 |
0.031 |
|
| 2012 |
Miller CP, Rattray K, Zhang Y, Wood BL, Burwick N, Chien S, Bensinger WI, Blau CA, Becker PS. Evaluating surface erythropoietin receptor in multiple myeloma Leukemia. 26: 1883-1886. PMID 22377897 DOI: 10.1038/leu.2012.58 |
0.026 |
|
| 1996 |
Blau CA, Stamatoyannopoulos G. Preemptive therapy for genetic disease. Nature Medicine. 2: 161-2. PMID 8574957 |
0.02 |
|
| Hide low-probability matches. |